June Zhao - AstraZeneca | 人才画像

基本信息

浏览量：9

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 26 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

HARMONIZE Asia: A Phase III Randomized Study to Investigate the Efficacy and Safety of Sodium Zirconium Cyclosilicate in Patients with Hyperkalemia in China

Xinling Liang,Wanhong Lu,Xueqing Yu,Hong Cheng,Qiang He,Qingfeng Peng,Zhaohui Ni,Gang Long,Lihua Wang,Wei Chen,Rong Li,June Zhao, Yong Zhang,Vera Lisovskaja, Zhiji Tang

CLINICAL THERAPEUTICSno. 9 (2024): 702-710

引用0浏览0WOS引用

DIALIZE China: A Phase IIIb, Randomized, Placebo-Controlled Study to Reduce Predialysis Hyperkalemia with Sodium Zirconium Cyclosilicate in Chinese Patients

Zhaohui Ni,Renhua Lu,Xudong Xu,Xueyan Bian,Zhihong Zhou,Junwei Yang,Qun Luo,Menghua Chen, Chaosheng Chen,Xiuli Sun,Lei Yu,Qiang He,Hong Jiang,Weijie Yuan, Yi Li, Rong Zhou,Jianqin Wang,Xinzhou Zhang,Li Zuo, Xiangwen Meng, Zhiren Chang,June Zhao,Peter Wessman

CLINICAL THERAPEUTICSno. 7 (2023): 633-642

引用5浏览0WOS引用

DIALIZE China: A Phase 3b Study to Reduce Pre-Dialysis Hyperkalemia with Sodium Zirconium Cyclosilicate in Chinese Subjects

June Zhao,Zhaohui Ni,Renhua Lu,Xudong Xu,Xueyan Bian,Zhou Zhihong,Junwei Yang,Qun Luo, Chen M. Hua,Chaosheng Chen,Xiuli Sun,Lei Yu,Qiang He,Hong Jiang,Wei jie Yuan, Yi Li, Rong Zhou,Wang Jianqin,Xinzhou Zhang,Li Zuo,Haijiao Jin, Xiangwen Meng, Zhiren Chang

Journal of the American Society of Nephrology（2022）

引用0浏览0引用

Phase I Study of the Pharmacodynamics and Safety of Sodium Zirconium Cyclosilicate in Healthy Chinese Adults

Tommy Cheung,Fang Sun,June Zhao,Yulin Qin,Mats Nagard

Clinical Pharmacology in Drug Development（2022）

引用4浏览0WOS引用

高カリウム血症の日本人被験者におけるナトリウムジルコニウムシクロケイ酸の長期安全性を研究するための第3相多施設オープンラベル維持研究【JST・京大機械翻訳】|||

Kashihara Naoki, Yoshimitsu Yamasaki, Takeshi Osonoi,Harada Hiromasa, Yugo Shibagaki,Zhao June, Kim Hyosung,Toshitaka Yajima,Sarai Nobuaki

openalex（2021）

引用0浏览0引用

P0189SODIUM ZIRCONIUM CYCLOSILICATE CORRECTS HYPERKALAEMIA WITHIN 72 HOURS AMONG OUTPATIENTS WITH SEVERE HYPERKALAEMIA (BASELINE SERUM POTASSIUM ≥6 MMOL/L) REGARDLESS OF RENAL FUNCTION LEVEL OR RAASI USE: POST HOC SUBGROUP ANALYSIS OF A PHASE 3 TRIAL

David Packham,Philip Lavin,Pablo Pergola,Mikhail Kosiborod,Edgar Lerma,June Zhao,Bhupinder Singh,Julian Martins,Steven Fishbane,Bruce Spinowitz,S Roger

Nephrology Dialysis Transplantationno. Supplement_3 (2020)

引用0浏览0引用

Efficacy and Safety of Sodium Zirconium Cyclosilicate for Hyperkalaemia: the Randomized, Placebo‐controlled HARMONIZE‐Global Study

Faiez Zannad,Bang-Gee Hsu,Yoshitaka Maeda,Sug Kyun Shin, Elena M. Vishneva, Martin Rensfeldt,Stefan Eklund,June Zhao

ESC Heart Failure（2020）

引用61浏览0WOS引用

A Phase 3 Multicenter Open-Label Maintenance Study to Investigate the Long-Term Safety of Sodium Zirconium Cyclosilicate in Japanese Subjects with Hyperkalemia

Kashihara Naoki, Yamasaki Yoshimitsu,Osonoi Takeshi,Harada Hiromasa,Shibagaki Yugo,Zhao June,Kim Hyosung,Yajima Toshitaka,Sarai Nobuaki

Clinical and Experimental Nephrology（2020）

引用11浏览0WOS引用

Sodium zirconium cyclosilicate corrects hyperkalaemia within 72 hours among outpatients with severe hyperkalaemia (baseline serum potassium 6 mmol/l) regardless of renal function level or raasi use: post hoc subgroup analysis of a phase 3 trial

David Packham,Philip Lavin,Pablo Pergola,Mikhail Kosiborod,Edgar Lerma,June Zhao,Bhupinder Singh,Julian Martins,Steven Fishbane,Bruce Spinowitz,S. Roger

NEPHROLOGY DIALYSIS TRANSPLANTATION（2020）

引用0浏览0引用

Op-ndtj190312 1..14

Simon D. Roger,Philip T. Lavin,Edgar V. Lerma,Peter A. McCullough,Javed Butler,Bruce S. Spinowitz,Stephan von Haehling,Mikhail Kosiborod,June Zhao,Steven Fishbane,David K. Packham

semanticscholar（2020）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn